Kemal BEKSAÇ
(Sağlık Bilimleri Üniversitesi, Dr.Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Genel Cerrahi Kliniği, Ankara, Türkiye)
Fatih AKTOZ
(Hacettepe Üniversitesi, Tıp Fakültesi, Perinatoloji Bölümü, Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara Türkiye)
Gökçen ÖRGÜL
(Hacettepe Üniversitesi, Tıp Fakültesi, Perinatoloji Bölümü, Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara Türkiye)
HASAN TOLGA ÇELİK
(Hacettepe Üniversitesi, Tıp Fakültesi, Neonatoloji Bölümü, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Ankara, Türkiye)
A. Seval ÖZGÜ ERDİNÇ
(Sağlık Bilimleri Üniversitesi, Dr.Zekai Tahir Burak Zekai Tahir Burak Kadın Sağlığı Uygulama ve Araştırma Merkezi, Üreme Endokrinolojisi Ayrımı, Ankara, Türkiye)
Mehmet Sinan BEKSAÇ
(Hacettepe Üniversitesi, Tıp Fakültesi, Perinatoloji Bölümü, Kadın Hastalıkları ve Doğum Anabilim Dalı, Ankara Türkiye)
Yıl: 2018Cilt: 19Sayı: 2ISSN: 1309-0399 / 1309-0380Sayfa Aralığı: 94 - 97İngilizce

92 0
Pregnancy in papillary thyroid cancer survivors
Objective: To evaluate “papillary thyroid carcinoma-pregnancy” interaction among cancer survivors.Material and Methods: The clinical records of 8 pregnant women who received treatment for papillary thyroid cancer before their pregnancy were evaluated. Clinical features, pregnancy/perinatal outcomes and high-risk factors were compared with 45 controls who were randomly assigned from the institutional perinatal medicine database.Results: Patients in the cancer group were older than the control group (34.3 vs 29.8 years). The cesarean section rate was higher (62.5% vs 33.3%) and the APGAR scores at the 1st and 5th minutes were lower in the cancer group.Conclusion: Management of pregnancies with papillary thyroid cancer treatment and follow-up requires a multidisciplinary approach with careful antenatal care and perinatal surveillance. Patients who have received papillary thyroid cancer treatment can safely undergo pregnancy. (J Turk Ger Gynecol Assoc 2018; 19: 94-7)
DergiAraştırma MakalesiErişime Açık
  • 1. Leenhardt L, Grosclaude P, Cherie-Challine L; Thyroid Cancer Committee. Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 2004; 14: 1056-60.
  • 2. Sungwalee W, Vatanasapt P, Kamsa-Ard S, Suwanrungruang K, Promthet S. Reproductive risk factors for thyroid cancer: a prospective cohort study in Khon Kaen, Thailand. Asian Pac J Cancer Prev 2013; 14: 5153-5.
  • 3. Xhaard C, Rubino C, Clero E, Maillard S, Ren Y, Borson-Chazot F, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study. Am J Epidemiol 2014; 180: 1007-17.
  • 4. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003; 189: 1128-35.
  • 5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29.
  • 6. Imran SA, Rajaraman M. Management of differentiated thyroid cancer in pregnancy. J Thyroid Res 2011; 2011: 549609.
  • 7. Uruno T, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K. Optimal timing of surgery for differentiated thyroid cancer in pregnant women. World J Surg 2014; 38: 704-8.
  • 8. Cabezon CA, Carrizo LC, Costanzo PR. Evolution of differentiated thyroid cancer during pregnancy in a community University Hospital in Buenos Aires, Argentina. Arq Bras Endocrinol Metabol 2013; 57: 307-11.
  • 9. Budak A, Gulhan I, Aldemir OS, Ileri A, Tekin E, Ozeren M. Lack of influence of pregnancy on the prognosis of survivors of thyroid cancer. Asian Pac J Cancer Prev 2013; 14: 6941-3.
  • 10. Shindo H, Amino N, Ito Y, Kihara M, Kobayashi K, Miya A, et al. Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid 2014; 24: 840-4.
  • 11. Lee JC, Zhao JT, Clifton-Bligh RJ, Gill AJ, Gundara JS, Ip J, et al. Papillary thyroid carcinoma in pregnancy: a variant of the disease? Ann Surg Oncol 2012; 19: 4210-6.
  • 12. Sioka C, Fotopoulos A. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer. Fertil Steril 2011; 95: 1552-9.
  • 13. Grammatikakis I, Trakakis E, Evangelinakis N, Hintipas E, Salamalekis G, Kassanos D. Successful pregnancy after radiotherapy with 131I for differentiated thyroid cancer. A case report and review of the literature. Clin Exp Obstet Gynecol 2010; 37: 328-30.
  • 14. Momotani N, Iwama S. [Management of Graves' disease and hypothyroidism in pregnancy]. Nihon Rinsho 2012; 70: 1971-5.
  • 15. Ma L, Qi H, Chai X, Jiang F, Mao S, Liu J, et al. The effects of screening and intervention of subclinical hypothyroidism on pregnancy outcomes: a prospective multicenter single-blind, randomized, controlled study of thyroid function screening test during pregnancy. J Matern Fetal Neonatal Med 2016; 29: 1391-4.
  • 16. Li X, Liu GY, Ma JL, Zhou L. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis. Clinics (Sao Pulo) 2015; 70: 453-9.
  • 17. Korevaar TI, Steegers EA, de Rijke YB, Visser WE, Jaddoe VW, Visser TJ, et al. Placental Angiogenic Factors Are Associated With Maternal Thyroid Function and Modify hCG-Mediated FT4 Stimulation. J Clin Endocrinol Metab 2015; 100: 1328-34.
  • 18. Alikhan M, Koshy A, Hyjek E, Stenson K, Cohen RN, Yeo KT. Discrepant serum and urine beta-hCG results due to production of beta-hCG by a cribriform-morular variant of thyroid papillary carcinoma. Clin Chim Acta 2015; 438: 181-5.
  • 19. Turgal M, Beksac K, Basaran D, Yazicioglu A, Ozyuncu O, Aran O, et al. Pregnancy after Cancer Treatment and Pregnancy Associated Cancer: A Single Center Experience with 96 Cases. Gynecology Obstetrics & Reproductive Medicine 2015; 21: 91-6.
  • 20. Bohinc BN, Perkins JM. Appropriate dosing of adjuvant radioactive iodine for differentiated thyroid cancer. Curr Opin Oncol 2014; 26: 31-5.
  • 21. Beksaç MS, Aydin E, Turgal M, Karaagaoglu E. An Obstetrics Index for the Assessment of Risk Levels of “High Risk Pregnancy” Groups. Gynecology Obstetrics & Reproductive Medicine 2015; 21: 10-3.
  • 22. Beksaç K, Örgül G, Çağan M, Karaağaoğlu E, Arslan S, Beksaç MS . Retrospective evaluation of pregnant women with celiac disease. J Turk Ger Gynecol Assoc 2017; 18: 56-59.
  • 23. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175-91.
  • 24. Yasmeen S, Cress R, Romano PS, Xing G, Berger-Chen S, Danielsen B, et al. Thyroid cancer in pregnancy. Int J Gynaecol Obstet 2005; 91: 15-20.
  • 25. Hershman JM. Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. Thyroid 1999; 9: 653-7.
  • 26. Guerrero-Vazquez R, Moreno Reina E, Gros Herguido N, Martinez Brocca MA, Navarro Gonzalez E. Advanced thyroid carcinoma in pregnancy: case report of two pregnancies. Gynecol Endocrinol 2015; 31: 852-5.
  • 27. Bresner L, Banach R, Rodin G, Thabane L, Ezzat S, Sawka AM. Cancer-related worry in Canadian thyroid cancer survivors. J Clin Endocrinol Metab 2015; 100: 977-85.
  • 28. Buchmann L, Ashby S, Cannon RB, Hunt JP. Psychosocial distress in patients with thyroid cancer. Otolaryngology Head Neck Surg 2015; 152: 644-9.
  • 29. Eskander A, Devins GM, Freeman J, Wei AC, Rotstein L, Chauhan N, et al. Waiting for thyroid surgery: a study of psychological morbidity and determinants of health associated with long wait times for thyroid surgery. Laryngoscope 2013; 123: 541-7.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.